SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015765
Filing Date
2023-06-16
Accepted
2023-06-16 16:15:13
Documents
1
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4175
  Complete submission text file 0000899243-23-015765.txt   5566
Mailing Address GLAXOSMITHKLINE THREE FRANKLIN PLAZA, 1600 VINE STREET PHILADELPHIA PA 19102
Business Address
LOKAY KEVIN G (Reporting) CIK: 0001211256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 231021276

Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations